相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Design and synthesis of potent PAR-1 antagonists based on vorapaxar
Mengna Fan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Effective Application of Metabolite Profiling in Drug Design and Discovery
Matthew A. Cerny et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Biotransformation: Impact and Application of Metabolism in Drug Discovery
Julia Shanu-Wilson et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Identification of bioactive metabolites using activity metabolomics
Markus M. Rinschen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Carboxylesterase 2 and Intestine Transporters Contribute to the Low Bioavailability of Allisartan, a Prodrug of Exp3174 for Hypertension Treatment in Humans
Xiuli Li et al.
DRUG METABOLISM AND DISPOSITION (2019)
A new generation of antidepressants: an update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate/GABA neurotransmitter systems
Samuel T. Wilkinson et al.
DRUG DISCOVERY TODAY (2019)
Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors
Nicki Niemann et al.
DRUGS (2018)
Metabolomics activity screening for identifying metabolites that modulate phenotype
Carlos Guijas et al.
NATURE BIOTECHNOLOGY (2018)
Cholic acid for primary bile acid synthesis defects: a life-saving therapy allowing a favorable outcome in adulthood
Emmanuel Gonzales et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
Peter Fickert et al.
JOURNAL OF HEPATOLOGY (2017)
Neuroactive Steroids. 2.3 alpha-Hydroxy-3 beta-methyl-21-(4-cyano-1H-pyrazol-1 '-yl)-19-nor-5 beta-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (gamma-Aminobutyric Acid)(A) Receptor
Gabriel Martinez Botella et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Discovery of Potent Orally Active Protease-Activated Receptor 1 (PAR1) Antagonists Based on Andrographolide
Jun Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Pharmacologic Characterization of Valbenazine (NBI-98854) and Its Metabolites
Dimitri E. Grigoriadis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Differences in Dihydrotetrabenazine Isomer Concentrations Following Administration of Tetrabenazine and Valbenazine
Heather Skor et al.
DRUGS IN R&D (2017)
Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures
Graciana L. Galiana et al.
DRUGS IN R&D (2017)
Deutetrabenazine: A Review in Chorea Associated with Huntington's Disease
Young-A Heo et al.
DRUGS (2017)
Role of Aramchol in Steatohepatitis and Fibrosis in Mice
Marta Iruarrizaga-Lejarreta et al.
HEPATOLOGY COMMUNICATIONS (2017)
Synthesis of novel and potent vorapaxar analogues
Emily Knight et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2016)
ATX-101 for reduction of submental fat
Uwe Wollina et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Novel antiplatelet agents in acute coronary syndrome
Francesco Franchi et al.
NATURE REVIEWS CARDIOLOGY (2015)
Classics in Chemical Neuroscience: Diazepam (Valium)
Nicholas E. Calcaterra et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Pharmacological profile of a 17β-heteroaryl-substituted neuroactive steroid
Derk J. Hogenkamp et al.
PSYCHOPHARMACOLOGY (2014)
Himbacine-Derived Thrombin Receptor Antagonists: C7-Spirocyclic Analogues of Vorapaxar
Mariappan V. Chelliah et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
Steady-state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteers
Teresa Nunes et al.
EPILEPSIA (2013)
Oncometabolites: linking altered metabolism with cancer
Ming Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Pharmacokinetics of vicagrel, a promising analog of clopidogrel, in rats and beagle dogs
Zhixia Qiu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Metabolism-guided drug design
Antonia F. Stepan et al.
MEDCHEMCOMM (2013)
Discovery of Octahydroindenes as PAR1 Antagonists
Sunkyung Lee et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Active Metabolites as Antidepressant Drugs: The Role of Norquetiapine in the Mechanism of Action of Quetiapine in the Treatment of Mood Disorders
Francisco López-Muñoz et al.
Frontiers in Psychiatry (2013)
Pharmacologically Active Drug Metabolites: Impact on Drug Discovery and Pharmacotherapy
R. Scott Obach
PHARMACOLOGICAL REVIEWS (2013)
Discovery of nor-seco himbacine analogs as thrombin receptor antagonists
Mariappan V. Chelliah et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Combined carbamazepine and pregabalin therapy in a rat model of neuropathic pain
T. S. Hahm et al.
BRITISH JOURNAL OF ANAESTHESIA (2012)
Overcoming Clopidogrel Resistance: Discovery of Vicagrel as a Highly Potent and Orally Bioavailable Antiplatelet Agent
Jiaqi Shan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Identification of Human Liver Cytochrome P450 Enzymes Involved in the Metabolism of SCH 530348 (Vorapaxar), a Potent Oral Thrombin Protease-Activated Receptor 1 Antagonist
Anima Ghosal et al.
DRUG METABOLISM AND DISPOSITION (2011)
Discovery of a vorapaxar analog with increased aqueous solubility
Yan Xia et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Metabolism and Disposition of the Thienopyridine Antiplatelet Drugs Ticlopidine, Clopidogrel, and Prasugrel in Humans
Nagy A. Farid et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Preparation and Characterization of Tetrabenazine Enantiomers against Vesicular Monoamine Transporter 2
Qian-sheng Yu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
Metabolites in Safety Testing: Metabolite Identification Strategies in Discovery and Development
Angus N. R. Nedderman
BIOPHARMACEUTICS & DRUG DISPOSITION (2009)
TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
Charles Thomas et al.
CELL METABOLISM (2009)
Metabolic Oxidative Cleavage of Thioesters: Evidence for the Formation of Sulfenic Acid Intermediates in the Bioactivation of the Antithrombotic Prodrugs Ticlopidine and Clopidogrel
Patrick M. Dansette et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
The Design and Development of Fesoterodine as a Prodrug of 5-Hydroxymethyl Tolterodine (5-HMT), the Active Metabolite of Tolterodine
B. Malhotra et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Discovery of 6α-Ethyl-23(S)-methylcholic Acid (S-EMCA, INT-777) as a Potent and Selective Agonist for the TGR5 Receptor, a Novel Target for Diabesity
Roberto Pellicciari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Cytochrome P-450 Polymorphisms and Response to Clopidogrel.
Jessica L. Mega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Physicochemical, Pharmacological and Pharmacokinetic Properties of the Zwitterionic Antihistamines Cetirizine and Levocetirizine
Chen Chen
CURRENT MEDICINAL CHEMISTRY (2008)
Olmesartan medoxomil - A review of its use in the management of hypertension
Lesley J. Scott et al.
DRUGS (2008)
Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity
Samuel Chackalamannil et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Heterotricyclic himbacine analogs as potent, orally active thrombin receptor (protease activated receptor-1) antagonists
Mariappan V. Chelliah et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
The disposition of prasugrel, a novel thienopyridine, in humans
Nagy A. Farid et al.
DRUG METABOLISM AND DISPOSITION (2007)
Metabolism-based identification of a potent thrombin receptor antagonist
Martin C. Clasby et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Desvenlafaxine succinate: A new serotonin and norepinephrine reuptake inhibitor
Darlene C. Deecher et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Role of pharmacologically active metabolites in drug discovery and development
A Fura
DRUG DISCOVERY TODAY (2006)
Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel -: Results of the ISAR-CHOICE (Intracoronary stenting and antithrombotic regimen:: Choose between 3 high oral doses for immediate clopidogrel effect) trial
N von Beckerath et al.
CIRCULATION (2005)
Discovery of potent orally active thrombin receptor (protease activated receptor 1) antagonists as novel antithrombotic agents
S Chackalamannil et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Discovering drugs through biological transformation: Role of pharmacologically active metabolites in drug discovery
A Fura et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
The discovery of ezetimibe: A view from outside the receptor
JW Clader
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Structure and stereochemistry of the active metabolite of clopidogrel
JM Pereillo et al.
DRUG METABOLISM AND DISPOSITION (2002)
6α-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity
R Pellicciari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Differential selectivity in carbamazepine-induced inactivation of cytochrome P450 enzymes in rat and human liver
Y Masubuchi et al.
ARCHIVES OF TOXICOLOGY (2001)
The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs
HR Davis et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2001)
P2Y12, a new platelet ADP receptor, target of clopidogrel
P Savi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Identification and biological activity of the active metabolite of clopidogrel
P Savi et al.
THROMBOSIS AND HAEMOSTASIS (2000)
Losartan and its metabolite E3174 modify cardiac delayed rectifier K+ currents
R Caballero et al.
CIRCULATION (2000)
Angiotensin II receptor antagonists
M Burnier et al.
LANCET (2000)
分享论文
